# Aptevo Therapeutics Inc.: Form 8-K, filed Aug 13, 2026

- Company: [Aptevo Therapeutics Inc.](/companies/apvo.md) (CIK 1671584)
- Form: 8-K
- Filed: 2026-08-13
- Accepted by EDGAR: Aug 13, 2026, 16:37 ET
- Period: 2026-08-12
- Accession: 0001193125-26-349380
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1671584/000119312526349380/apvo-20260812.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1671584/000119312526349380/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1671584/000119312526349380/apvo-20260812.htm

Filed Aug 13, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-349380. Last ingested by Listed: Nov 14, 2026, 12:03 ET. No prices; not investment advice.
